Johnson & Johnson
JNJ · As of 2026-07-24
$263.40
·
1.99%
Latest close & trailing twelve-month yield
Sector: HEALTHCARE
JNJ S&P 500
Adjusted close price
Annualized Compounded Stock Growth
Annual dividends — last 10 years
Stock Volatility
Debug
Symbol index
- Stocks rows: 7091
- ETFs rows: 5187
- Symbol count: 12278
Alpha Vantage OVERVIEW — JNJ
| Symbol | JNJ |
| AssetType | Common Stock |
| Name | Johnson & Johnson |
| Description | Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. |
| CIK | 200406 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NJ, UNITED STATES, 08933 |
| OfficialSite | https://www.jnj.com |
| FiscalYearEnd | December |
| LatestQuarter | 2026-06-30 |
| MarketCapitalization | 624119120000 |
| EBITDA | 34839998000 |
| PERatio | 29.66 |
| PEGRatio | 4.227 |
| BookValue | 33.73 |
| DividendPerShare | 5.24 |
| DividendYield | 0.0205 |
| EPS | 8.74 |
| RevenuePerShareTTM | 40.51 |
| ProfitMargin | 0.215 |
| OperatingMarginTTM | 0.286 |
| ReturnOnAssetsTTM | 0.0842 |
| ReturnOnEquityTTM | 0.264 |
| RevenueTTM | 97929003000 |
| GrossProfitTTM | 66687001000 |
| DilutedEPSTTM | 8.74 |
| QuarterlyEarningsGrowthYOY | -0.01 |
| QuarterlyRevenueGrowthYOY | 0.066 |
| AnalystTargetPrice | 270.59 |
| AnalystRatingStrongBuy | 5 |
| AnalystRatingBuy | 10 |
| AnalystRatingHold | 7 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 29.66 |
| ForwardPE | 21.98 |
| PriceToSalesRatioTTM | 6.37 |
| PriceToBookRatio | 7.58 |
| EVToRevenue | 6.62 |
| EVToEBITDA | 24.48 |
| Beta | 0.235 |
| 52WeekHigh | 269.43 |
| 52WeekLow | 160.21 |
| 50DayMovingAverage | 241.15 |
| 200DayMovingAverage | 224.26 |
| SharesOutstanding | 2407217000 |
| SharesFloat | 2403221000 |
| PercentInsiders | 0.047 |
| PercentInstitutions | 76.907 |
| DividendDate | 2026-09-08 |
| ExDividendDate | 2026-08-25 |